Regulatory & Compliance

California AI Transparency Act to Impact High-Traffic Health Websites
Regulatory & Compliance California AI Transparency Act to Impact High-Traffic Health Websites

Emerging legislation in California, known as the California AI Transparency Act, could bring significant changes to healthcare companies and other businesses operating high-traffic websites. Designed to enhance transparency and accountability, this bill focuses on content generated by artificial

Are Pharmacy Benefit Managers Behind Soaring Insulin Prices?
Regulatory & Compliance Are Pharmacy Benefit Managers Behind Soaring Insulin Prices?

The cost of insulin has surged dramatically over the past decades, burdening patients who rely on this life-saving medication. Rising costs have drawn scrutiny from regulators, lawmakers, and consumers, leading to investigations into the pharmaceutical industry's pricing mechanisms. Among the

Boston Scientific Acquires Silk Road Medical for $1.28 Billion
Regulatory & Compliance Boston Scientific Acquires Silk Road Medical for $1.28 Billion

The healthcare industry witnessed a significant move today as Boston Scientific announced the completion of its acquisition of Silk Road Medical. This transaction, valued at $1.28 billion, represents a strategic milestone for Boston Scientific, aiming to enhance their technological prowess in the

Enhancing Cyber Resilience in Healthcare: Strategies and Challenges
Regulatory & Compliance Enhancing Cyber Resilience in Healthcare: Strategies and Challenges

The healthcare sector is continuously evolving, but along with these advancements come increased vulnerabilities to cyber threats. Cyber resilience has thus become paramount. This article explores the dynamic landscape of cyber resilience in the healthcare industry, the key challenges, and the

Will the BIOSECURE Act Hinder Innovation in U.S. Biotechnology?
Regulatory & Compliance Will the BIOSECURE Act Hinder Innovation in U.S. Biotechnology?

Amid rising concerns over national security and economic self-reliance, the U.S. Congress has introduced the BIOSECURE Act. Aimed at curbing Chinese influence in the biotechnology sector, this legislation prevents companies with Chinese ties from accessing federal funding. While the Act promises

Labs Urge Lawmakers to Rescind FDA Rule on Lab-Developed Tests
Regulatory & Compliance Labs Urge Lawmakers to Rescind FDA Rule on Lab-Developed Tests

The call for legislative intervention to overturn the FDA's final rule on the regulation of laboratory-developed tests (LDTs) has intensified. The Association for Diagnostics and Laboratory Medicine (ADLM) has been at the forefront, urging lawmakers to take action against the FDA's new

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later